Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
ß The Author 2010; all rights reserved. Advance Access publication 5 October 2010 doi:10.1093/ije/dyq165
CARDIOVASCULAR DISEASE
139
140 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Conclusions This article presents the 2008–09 revision of the World Health
Organization (WHO) definition of myocardial infarction (MI) devel-
oped at a WHO expert consultation.
Keywords Myocardial infarction, epidemiology, clinical diagnosis, ischeamic
heart disease, atherosclerosis
The WHO European Myocardial Infarction registry coronary heart disease is rising. The new definition
criteria7 were based on clinical history, findings on cannot easily be used to identify non-fatal events
the electrocardiogram (ECG), enzyme measurements with incomplete information on cardiac biomarkers,
in blood and postmortem findings. MI was diagnosed or fatal events occurring in or out of hospital with
in the presence of one of the following: incomplete information on cardiac biomarkers, with
or without only one ECG recording and/or availability
(i) ECG showing unequivocal pathological Q waves of autopsy data and/or information from coronary
and/or ST segment elevation or depression in angiography. Furthermore, events in patients reaching
serial recordings; hospital, although suspect, may not have complete
or clinical information, including measurement of the
new biomarkers. A major problem with the revised
(ii) history of typical or atypical angina pectoris, definition14 is that although it is quite appropriate
(ii) Death with a history of coronary heart disease Definition of a prior MI (same as the ESC/ACC/AHA/
and/or documented cardiac pain within 72 h WHF definition),14 ICD-10 code: I 25.2
before death and no evidence of non-coronary The term prior MI should be used in the presence of
cause of death, or autopsy evidence of chronic any one of the following:
coronary heart disease, including coronary ath-
(i) pathological Q waves [any Q wave in leads
erosclerosis and myocardial scarring.
V2–V3 50.02 s—Minnesota code 1.2.1—or QS
complex in leads V2 and V3—Minnesota code
1.2.7. Q-wave 50.03 s and 50.1 mV deep—
Category C definition and diagnostic criteria of Minnesota codes 1.1.1; 1.2.2—or QS complex
probable MI. ICD-10 code: I 24.9 in leads I, II, aVL, aVF or V4–V6 in any two
In resource-constrained settings, individuals with MI leads of a contiguous lead grouping I, aVL,
may not satisfy criteria of definitions in Category A V6: V4–V6: II, III, aVF (Minnesota codes
reference limit are considered diagnostic. It is essential The Category C definition of probable MI is required
that the increases occur from a normal baseline. If mainly because of inequities in access to health
values are rising, distinguishing between the rise due services that prevail in low-resource settings.
to the acute event (whether appreciated or not) or due Furthermore, in settings where resources are very
to the procedure itself is difficult. constrained, situations may arise where even the
By convention, for coronary artery bypass grafting– tests required for a diagnosis of probable MI are
related MI, cardiac biomarkers values five times not available and other reasons for the symptoms
greater than the 99th-percentile upper reference are not known. In countries where this is like-
limit plus either new pathological Q waves or new ly to happen, the use of code ‘unclassifiable
LBBB or angiographically documented new graft or MI’ should be considered for epidemiological
native coronary artery occlusion or imaging evidence purposes.
of new loss of viable myocardium are considered When feasible, the diagnosis of acute MI should
There will be some advantages and disadvantages there is insufficient evidence to classify the event as
with these revised definitions. For the individual a coronary death, and there is no other known cause.
patient, the new definition may cause changes in The number of such deaths may be substantial.10 It is
the eligibility to continue in certain occupations and important for the epidemiological reporting that such
the ability of persons to obtain insurance. Many deaths are also monitored.
patients who in the past would have been diagnosed
as having unstable angina will now be diagnosed as
having had an MI. Funding
The application of the more sensitive new diagnostic
The expert consultation and other expenses were
criteria for MI will cause the recorded incidence of MI
funded by World Health Organization.
to rise and the case fatality to fall with a reduction in
false-positive and false-negative cases. This may
confuse efforts to follow trends in disease rates and
outcomes that are used to evaluate the impact of Acknowledgements
public health measures and treatment.19–21 There will The contribution of all experts who participated in the
be significant health resource and cost implications but consultation and that of the experts who prepared
expenditures will be better directed as a consequence of background papers and peer reviewed the article are
more accurate diagnosis, improved patient outcomes greatly appreciated. They include: Dr Joseph S Alpert,
and decreased mortality rates. Dr Pascal Bovet, Dr Albertino Damasceno, Dr Allan S
Comparison with previous epidemiological studies Jaffe, Dr Clayborne Johnston, Dr Porfirio Nordet, Dr
using the old definition will be problematic. When Karen Sliwa, Dr Harvey D White, Dr Salim Yusuf, Dr
interpreting trends and comparing data collected in Dong Zhao. The content under subheadings ‘Category
different settings, there is a need to take note of the A definition and diagnostic criteria of MI’ and
different definitions that may have been used in ‘Definition of a prior MI and Peri-procedural MI’ are
collecting the data. For accurate tracking of MI taken from reference 14. This report contains the col-
rates, methods for adjusting the new criteria to the lective views of an international group of experts and
old may be required. For example, specific surveil- does not necessarily represent the decisions or the
lance centres in LMICs may be needed to measure policies of the World Health Organization
total CK and CK-MB together with new biomarkers Conflict of interest: None declared.
for a transition period, or to apply both new and old
diagnostic criteria for a given period of time to assess
the difference in terms of incidence, prevalence and
mortality rates. References
A specific problem for the assessment of event rates 1
World Health Organization. Reducing Risks, Promoting
and their trends in the population is death when Healthy Life. WHO Report. Geneva: WHO, 2002.
146 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
2
World Health Organization. World Health Statistics 2008. redefined: a consensus document of the Joint
Geneva: WHO, 2008. EUROPEAN Society of Cardiology/American College of
3
World Health Organization. Prevention of Cardiovascular Cardiology Committee for the redefinition of myocardial
Disease: Guidelines for Assessment and Management of Total infarction. Eur Heart J 2000;21:1502–13.
13
Cardiovascular Risk. Geneva: WHO, 2007. Luepker RV, Apple FS, Christenson RH et al. Case defin-
4 itions for acute coronary heart disease in epidemiology
World Health Organization. Preventing Chronic Diseases–A
Vital Investment. Geneva: WHO, 2005. and clinical research studies: a statement from the AHA
5
Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially Council on Epidemiology and Prevention; AHA Statistics
modifiable risk factors associated with myocardial infarc- Committee; World Heart Federation Council on
tion in 52 countries (the INTERHEART study): case– Epidemiology and Prevention; the European Society of
control study. Lancet 2004;364:937–52. Cardiology Working Group on Epidemiology and
6 Prevention; Centers for Disease Control and Prevention;
World Health Organization. Hypertension and coronary
and the National Heart, Lung, and Blood Institute.
heart disease: classification and criteria for epidemiological